Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1997
Polyglucose solutions in CAPD
M E Wilkie, C B Brown
Drugs
|
May 5, 2016
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
S N Salam, A Khwaja, M E Wilkie
The Journal of Infection
|
September 1, 1988
Infection with Campylobacter coli and Campylobacter fetus in a patient on continuous ambulatory peritoneal dialysis
J A Meigh, M E Wilkie, P Ackrill
BMJ (Clinical Research Ed.)
|
November 7, 1992
Diagnosis and management of urinary tract infection in adults
M E Wilkie, M K Almond, F P Marsh
Digestive Diseases and Sciences
|
March 1, 1993
Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability
G R Davies, M E Wilkie, D S Rampton
European Journal of Clinical Nutrition
|
May 1, 1993
Dual energy X-ray absorptiometry versus skinfold measurements in the assessment of total body fat in renal transplant recipients
P D Hart, M E Wilkie, A Edwards, et al.
Mineral and Electrolyte Metabolism
|
January 1, 1992
Hypoxia-induced von Willebrand factor release is blocked by verapamil
M E Wilkie, C R Stevens, J Cunningham, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1997
Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival
M E Wilkie, M J Plant, L Edwards, et al.
Clinical Nephrology
|
December 1, 1992
Effects of indomethacin and misoprostol on renal function in healthy volunteers
M E Wilkie, G R Davies, F P Marsh, et al.
Nephron. Clinical Practice
|
January 17, 2009
Encapsulating peritoneal sclerosis: clinical significance and implications
T Augustine, P W Brown, S D Davies, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1997
Polyglucose solutions in CAPD
M E Wilkie, C B Brown
Drugs
|
May 5, 2016
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
S N Salam, A Khwaja, M E Wilkie
The Journal of Infection
|
September 1, 1988
Infection with Campylobacter coli and Campylobacter fetus in a patient on continuous ambulatory peritoneal dialysis
J A Meigh, M E Wilkie, P Ackrill
BMJ (Clinical Research Ed.)
|
November 7, 1992
Diagnosis and management of urinary tract infection in adults
M E Wilkie, M K Almond, F P Marsh
Digestive Diseases and Sciences
|
March 1, 1993
Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability
G R Davies, M E Wilkie, D S Rampton
European Journal of Clinical Nutrition
|
May 1, 1993
Dual energy X-ray absorptiometry versus skinfold measurements in the assessment of total body fat in renal transplant recipients
P D Hart, M E Wilkie, A Edwards, et al.
Mineral and Electrolyte Metabolism
|
January 1, 1992
Hypoxia-induced von Willebrand factor release is blocked by verapamil
M E Wilkie, C R Stevens, J Cunningham, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1997
Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival
M E Wilkie, M J Plant, L Edwards, et al.
Clinical Nephrology
|
December 1, 1992
Effects of indomethacin and misoprostol on renal function in healthy volunteers
M E Wilkie, G R Davies, F P Marsh, et al.
Nephron. Clinical Practice
|
January 17, 2009
Encapsulating peritoneal sclerosis: clinical significance and implications
T Augustine, P W Brown, S D Davies, et al.
Page
of 2